Skip to main content
. 2013 Jan 3;3:1. doi: 10.1186/2191-219X-3-1

Table 2.

Nuclear medicine imaging studies with VAP-1 targeting agents

Imaging agent Imaged condition Reference
123I-labeled anti-human-VAP-1 mAb 1B2
Animal models of skin inflammation and aseptic arthritis
[31]
68Ga-labeled VAP-1 binding peptide, 68Ga-DOTAVAP-P1
Animal model of osteomyelitis
[37,38]
68Ga-labeled VAP-1 binding peptide, 68Ga-DOTAVAP-P1
Animal model of sterile skin inflammation and pancreatic adenocarcinoma xenograft in rat
[39]
68Ga-labeled VAP-1 binding peptide, 68Ga-DOTAVAP-PEG-P1
Animal model of sterile skin inflammation in rat
[40]
68Ga-labeled VAP-1 binding peptide, 68Ga-DOTA-Siglec-9 peptide Animal model of sterile skin inflammation in rat, DNBC-induced skin inflammation in hVAP-1 transgenic mouse and VAP-1 knockout mouse [41]